142 related articles for article (PubMed ID: 9753474)
1. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
[TBL] [Abstract][Full Text] [Related]
2. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
Young PR; McLaughlin MM; Kumar S; Kassis S; Doyle ML; McNulty D; Gallagher TF; Fisher S; McDonnell PC; Carr SA; Huddleston MJ; Seibel G; Porter TG; Livi GP; Adams JL; Lee JC
J Biol Chem; 1997 May; 272(18):12116-21. PubMed ID: 9115281
[TBL] [Abstract][Full Text] [Related]
3. Kinetic mechanism for p38 MAP kinase.
LoGrasso PV; Frantz B; Rolando AM; O'Keefe SJ; Hermes JD; O'Neill EA
Biochemistry; 1997 Aug; 36(34):10422-7. PubMed ID: 9265622
[TBL] [Abstract][Full Text] [Related]
4. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.
Kumar S; Jiang MS; Adams JL; Lee JC
Biochem Biophys Res Commun; 1999 Oct; 263(3):825-31. PubMed ID: 10512765
[TBL] [Abstract][Full Text] [Related]
5. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
Kalmes A; Deou J; Clowes AW; Daum G
FEBS Lett; 1999 Feb; 444(1):71-4. PubMed ID: 10037150
[TBL] [Abstract][Full Text] [Related]
6. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
8. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level.
Pietersma A; Tilly BC; Gaestel M; de Jong N; Lee JC; Koster JF; Sluiter W
Biochem Biophys Res Commun; 1997 Jan; 230(1):44-8. PubMed ID: 9020057
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides.
Chen G; Porter MD; Bristol JR; Fitzgibbon MJ; Pazhanisamy S
Biochemistry; 2000 Feb; 39(8):2079-87. PubMed ID: 10684658
[TBL] [Abstract][Full Text] [Related]
10. Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.
Detmers PA; Zhou D; Polizzi E; Thieringer R; Hanlon WA; Vaidya S; Bansal V
J Immunol; 1998 Aug; 161(4):1921-9. PubMed ID: 9712062
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin (IL)-2 receptor beta-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein Kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activation.
Hunt AE; Lali FV; Lord JD; Nelson BH; Miyazaki T; Tracey KJ; Foxwell BM
J Biol Chem; 1999 Mar; 274(11):7591-7. PubMed ID: 10066828
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for p38 protein kinase inhibitor specificity.
Lisnock J; Tebben A; Frantz B; O'Neill EA; Croft G; O'Keefe SJ; Li B; Hacker C; de Laszlo S; Smith A; Libby B; Liverton N; Hermes J; LoGrasso P
Biochemistry; 1998 Nov; 37(47):16573-81. PubMed ID: 9843424
[TBL] [Abstract][Full Text] [Related]
13. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
[TBL] [Abstract][Full Text] [Related]
14. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase.
Lali FV; Hunt AE; Turner SJ; Foxwell BM
J Biol Chem; 2000 Mar; 275(10):7395-402. PubMed ID: 10702313
[TBL] [Abstract][Full Text] [Related]
15. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
[TBL] [Abstract][Full Text] [Related]
16. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
Kumar S; McDonnell PC; Gum RJ; Hand AT; Lee JC; Young PR
Biochem Biophys Res Commun; 1997 Jun; 235(3):533-8. PubMed ID: 9207191
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket.
Gum RJ; McLaughlin MM; Kumar S; Wang Z; Bower MJ; Lee JC; Adams JL; Livi GP; Goldsmith EJ; Young PR
J Biol Chem; 1998 Jun; 273(25):15605-10. PubMed ID: 9624152
[TBL] [Abstract][Full Text] [Related]
18. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase.
Miyazawa K; Mori A; Miyata H; Akahane M; Ajisawa Y; Okudaira H
J Biol Chem; 1998 Sep; 273(38):24832-8. PubMed ID: 9733787
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
